The FDA issued recent updates regarding drugs that are currently in shortage or have been discontinued:
- Asparaginase Erwinia Chrysanthemi (Erwinaze) (Updated – Currently in Shortage)
- Atropine Sulfate Injection (Updated – Currently in Shortage)
- Bupivacaine Hydrochloride and Epinephrine Injection, USP (Updated – Currently in Shortage)
- Bupivacaine Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Calcium Gluconate Injection (Updated – Currently in Shortage)
- Cefotetan Disodium Injection (Updated – Currently in Shortage)
- Deferoxamine Mesylate for Injection, USP (Updated – Currently in Shortage)
- Dextrose 5% Injection Bags (Updated – Currently in Shortage)
- Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution (Updated – Currently in Shortage)
- Dorzolamide Hydrochloride Ophthalmic Solution (Updated – Currently in Shortage)
- Etoposide Injection (Updated – Currently in Shortage)
- Guanfacine Hydrochloride Tablets (Updated – Currently in Shortage)
- Hydromorphone Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Ketamine Injection (Updated – Currently in Shortage)
- Leucovorin Calcium Lyophilized Powder for Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine (Updated – Currently in Shortage)
- Methotrexate Sodium Injection (Updated – Currently in Shortage)
- Metoclopramide Injection, USP (Updated – Currently in Shortage)
- Morphine Sulfate Injection, USP (Updated – Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated – Currently in Shortage)
- Potassium Chloride Injection (Updated – Currently in Shortage)
- Remifentanil (Ultiva) Lyophilized Powder for Solution Injection (Updated – Currently in Shortage)
- Sodium Chloride 0.9% Injection Bags (Updated – Currently in Shortage)
- Sodium Chloride 23.4% Injection (Updated – Currently in Shortage)
- Sodium Phosphate Injection (Updated – Currently in Shortage)
- Sterile Water (Updated – Currently in Shortage)
- Telmisartan and Amlodipine (Twynsta) Tablets (New – Discontinuation)
According to the FDA:
“A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. However, some manufacturers may not have all presentations available. DSS monitors the supply of products with Resolved status. For the most current supply information, contact the manufacturers.”
(Source: U.S. Food & Drug Adminstration)
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!